Cutting-balloon angioplasty before drug-eluting stent implantation for the treatment of severely calcified coronary lesions

Zhe Tang, Jing Bai, Shao-Ping Su, Yu Wang, Mo-Han Liu, Qi-Cai Bai, Jin-Wen Tian, Qiao Xue, Lei Gao, Chun-Xiu An, Xiao-Juan Liu, Zhe Tang, Jing Bai, Shao-Ping Su, Yu Wang, Mo-Han Liu, Qi-Cai Bai, Jin-Wen Tian, Qiao Xue, Lei Gao, Chun-Xiu An, Xiao-Juan Liu

Abstract

Background: Severely calcified coronary lesions respond poorly to balloon angioplasty, resulting in incomplete and asymmetrical stent expansion. Therefore, adequate plaque modification prior to drug-eluting stent (DES) implantation is the key for calcified lesion treatment. This study was to evaluate the safety and efficacy of cutting balloon angioplasty for severely calcified coronary lesions.

Methods: Ninety-two consecutive patients with severely calcified lesions (defined as calcium arc ≥ 180° calcium length ratio ≥ 0.5) treated with balloon dilatation before DES implantation were randomly divided into two groups based on the balloon type: 45 patients in the conventional balloon angioplasty (BA) group and 47 patients in the cutting balloon angioplasty (CB) group. Seven cases in BA group did not satisfactorily achieve dilatation and were transferred into the CB group. Intravascular ultrasound (IVUS) was performed before balloon dilatation and after stent implantation to obtain qualitative and quantitative lesion characteristics and evaluate the stent, including minimum lumen cross-sectional area (CSA), calcified arc and length, minimum stent CSA, stent apposition, stent symmetry, stent expansion, vessel dissection, and branch vessel jail. In-hospital, 1-month, and 6-month major adverse cardiac events (MACE) were reported.

Results: There were no statistical differences in clinical characteristics between the two groups, including calcium arc (222.2° ± 22.2° vs. 235.0° ± 22.1°, P = 0.570), calcium length ratio (0.67 ± 0.06 vs. 0.77 ± 0.05, P = 0.130), and minimum lumen CSA before PCI (2.59 ± 0.08 mm(2) vs. 2.52 ± 0.08 mm(2), P = 0.550). After stent implantation, the final minimum stent CSA (6.26 ± 0.40 mm(2) vs. 5.03 ± 0.33 mm(2); P = 0.031) and acute lumen gain (3.74 ± 0.38 mm(2) vs. 2.44 ± 0.29 mm(2), P = 0.015) were significantly larger in the CB group than that of the BA group. There were not statistically differences in stent expansion, stent symmetry, incomplete stent apposition, vessel dissection and branch vessel jail between two groups. The 30-day and 6-month MACE rates were also not different.

Conclusions: Cutting balloon angioplasty before DES implantation in severely calcified lesions appears to be more efficacies including significantly larger final stent CSA and larger acute lumen gain, without increasing complications during operations and the MACE rate in 6-month.

Keywords: Calcified lesion; Cutting balloon angioplasty; Intravascular ultrasound; Percutaneous coronary intervention.

Figures

Figure 1.. Lumen CSA before and after…
Figure 1.. Lumen CSA before and after stent implantation.
BA: conventional balloon angioplasty; CB: cutting balloon angioplasty; CSA: cross-sectional area.
Figure 2.. The lumen before (A) and…
Figure 2.. The lumen before (A) and after (B) CB dilatation.
Arrows showed the gap after dilatation. BA: conventional balloon angioplasty.

References

    1. Ellis SG, Vandormael MG, Cowley MJ, et al. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. Circulation. 1990;82:1193–202.
    1. Fitzgerald PJ, Ports TA, Yock PG. Contribution of localized calcium deposits to dissection after angioplasty. An observational study using intravascular ultrasound. Circulation. 1992;86:64–70.
    1. Tanigawa J, Barlis P, Di Mario C. Heavily calcified coronary lesions preclude strut apposition despite high pressure balloon dilatation and rotational atherectomy: in-vivo demonstration with optical coherence tomography. Circ J. 2008;72:157–160.
    1. Reimers B, von Birgelen C, van der Giessen WJ, et al. A word of caution on optimizing stent deployment in calcified lesions: acute coronary rupture with cardiac tamponade. Am Heart J. 1996;131:192–194.
    1. Fujii K, Carlier SG, Mintz GS, et al. Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation. J Am Coll Cardiol. 2005;45:995–998.
    1. Sonoda S, Morino Y, Ako J, et al. Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol. 2004;43:1959–1963.
    1. Furuichi S, Sangiorgi GM, Godino C, et al. Rotational atherectomy followed by drug-eluting stent implantation in calcified coronary lesions. EuroIntervention. 2009;5:370–374.
    1. Chiang MH, Yi Ht, Tsao CR, et al. Rotablation in the treatment of high-risk patients with heavily calcified left-main coronary lesions. J Geriatr Cardiol. 2013;10:217–225.
    1. Levine GN, Bates ER, Blankenship JC, et al. 2011 ACCF/ AHA/SCAI guideline for percutaneous coronary intervention. A report of the American college of cardiology foundation/American Heart Association task force on practice guidelines and the society for cardiovascular angiography and interventions. J Am Coll Cardiol. 2011;58:44–122.
    1. Asakura Y, Furukawa Y. Successful predilation of a resistant, heavily calcified lesion with cutting balloon for coronary stenting: a case report. Cathet Cardiovasc Diagn. 1998;44:420–422.
    1. Kang WC, Ahn TH, Han SH, et al. Successful management of a resistant, focal calcified lesion following direct coronary stenting with a cutting balloon. J Invasive Cardiol. 2004;16:725–726.
    1. Karvouni E, Stankovic G, Albiero R, et al. Cutting balloon angioplasty for treatment of calcified coronary lesions. Catheter Cardiovasc Interv. 2001;54:473–481.
    1. Mintz GS, Nissen SE, Anderson WD, et al. American college of cardiology clinical expert consensus document on standards for acquisition, measurement and reporting of intravascular ultrasound studies (IVUS) J Am Coll Cardiol. 2001:1478–1492.
    1. Thygesen K, Alpert JS, Jaffe AS, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol. 2012;60:1581–1598.
    1. Hsu JT, Kyo E, Chu CM, et al. Impact of calcification length ratio on the intervention for chronic total occlusions. Int J Cardiol. 2011;150:135–141.
    1. Kronmal RA, McClelland RL, Detrano R, et al. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of atherosclerosis (MESA) Circulation. 2007;115:2722–2730.
    1. Roy P, Steinberg DH, Sushinsky SJ, et al. The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug- eluting stents. Eur Heart J. 2008;29:1851–1857.
    1. Song HG, Kang SJ, Ahn JM, et al. Intravascular ultrasound assessment of optimal stent area to prevent in-stent restenosis after zotarolimus-, everolimus- and sirolimus-eluting stent implantation. Catheter Cardiovasc Interv. doi: 10.1002/ccd.24560. Published Online First: 19 July 2012.
    1. Barath P, Fishbein MC, Vari S, et al. Cutting balloon: a novel approach to percutaneous angioplasty. Am J Cardiol. 1991;68:1249–1252.
    1. Okura H, Hayase M, Shimodozono S, et al. Mechanisms of acute lumen gain following cutting balloon angioplasty in calcified and noncalcified Lesions: An Intravascular Ultrasound Study. Catheter Cardiovasc Interv. 2002;57:429–436.

Source: PubMed

Sponsorit ja yhteistyökumppanit

Sairaudet

Huumeiden interventiot

3
Tilaa